Muse cells are a unique type of naturally occurring, non-tumorigenic stem cell that can be collected from sources like bone marrow or adipose tissue. When administered, they selectively travel to sites of injury or inflammation to repair and regenerate damaged tissue. The healthspan hypothesis is that this therapy could systemically reverse age-related cellular damage, reduce chronic inflammation, and restore organ function.
Verdict
A promising but highly experimental therapy, not ready for healthspan applications.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
High
EVIDENCE GRADE
C
MONTHLY COST
$50000 - $150000
Protocol
- This is an experimental therapy currently administered within clinical trials for specific diseases, not as a healthspan protocol.
Flags
- Currently available only within clinical trials for specific indications like stroke or heart attack.
- Not approved as a general anti-aging or healthspan therapy by any major regulatory body.
- Long-term effects of systemic administration in healthy individuals are completely unknown.
- Extremely high cost and very limited accessibility.